CellSeed (TSE:7776) Inventories, Work In Process: 円1.43 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7776 CellSeed Inc TSE:7776
55 GF Score
Price 円226.00
GF Value 円162.45
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is CellSeed Inventories, Work In Process?

CellSeed TSE:7776 +0.44% 55 Inventories, Work In Process is 円1.43 Mil as of Dec. 2025. GuruFocus rates TSE:7776 with a GF Score™ of 55/100 and a GF Value™ of 円162.45 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. CellSeed's work in process for the quarter that ended in Dec. 2025 was 円1.43 Mil.

CellSeed Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for CellSeed's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CellSeed Inventories, Work In Process Chart

CellSeed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.76 0.84 4.29 9.45 1.43

CellSeed Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 4.90 0.61 1.43 9.77
TSE:7776
55GF Score
CellSeed Inc TSE:7776
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CellSeed Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of 円1.43 Mil mean?
CellSeed (TSE:7776) has a Inventories, Work In Process of 円1.43 Mil as of Dec. 2025. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on CellSeed and its competitors.
Is CellSeed's Inventories, Work In Process too high?
CellSeed's current Inventories, Work In Process is 円1.43 Mil. Overall, CellSeed has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CellSeed's Inventories, Work In Process compare to VRTX and REGN?
CellSeed's Inventories, Work In Process of 円1.43 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Biotechnology company?
A good Inventories, Work In Process depends on the Biotechnology industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on CellSeed and its competitors. CellSeed's current Inventories, Work In Process is 円1.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CellSeed stock overvalued right now?
Based on GuruFocus' analysis, CellSeed (TSE:7776) is currently considered Significantly Overvalued. The stock's GF Value™ is 円162.45, compared to a current price of 円226.00 — trading 39.1% above its estimated fair value. The current Inventories, Work In Process is 円1.43 Mil. CellSeed's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For CellSeed (TSE:7776), the current Inventories, Work In Process is 円1.43 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CellSeed (TSE:7776) Overvalued in 2026?

Based on GuruFocus' analysis, CellSeed stock appears to be overvalued. The current stock price of 円226.00 is trading 39.1% above its estimated GF Value™ of 円162.45. GuruFocus considers CellSeed to be Significantly Overvalued.

Key valuation signals for TSE:7776:

  • Inventories, Work In Process: 円1.43 Mil
  • GF Value™: 円162.45 vs. price of 円226.00 (39.1% above fair value)
  • GF Score™: 55/100 with 4 warning signs

No single metric tells the full story. See the TSE:7776 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CellSeed Business Description

Address 2-5-10 Aomi, Telecom Center Building, 15th Floor (East Wing, Koto-ku, Tokyo, JPN, 135-0064
CellSeed Inc is a Japanese biotechnology company. The company is involved in the research, development, marketing, and sale of cell-sheet regenerative medicines, such as epithelial cell sheets for corneal and esophageal regeneration; regenerated cardiac patches to treat heart diseases; cell sheets for periodontal tissue regeneration; and regenerated cartilage sheets for the treatment of osteoarthritis.
55GF Score

Get the complete analysis for TSE:7776

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円226.00
Price
円162.45
GF Value